Abattis Completes Audit and Prepares to Launch Northern Vine Labs (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (“ATT” or the “Company”) is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and […]

Abattis Explores Diversifying with a Strategic Acquisition (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Jan 19, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. ( OTC PINK : ATTBF ) ( CNSX : ATT ), a specialty agricultural technology firm focused on the legal cannabis industry. […]

Abattis Announces an Independent Valuation on Green Nature Health Care Products (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / January 16, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholders. Abattis Bioceuticals Corp. has begun an independent valuation on Green Nature Health Care Products Inc. after the company posted strong performance within their existing and upcoming product catalogue in both Q3 and […]

Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business (CFN Media)

0 Responses Abattis News

SEATTLE, WA / Marketwired / Nov 28, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) recent expansion of distribution lines in Asia and how those efforts complement […]

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / November 14, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity. Abattis is also pleased provide an update on […]